News
Eli Lilly says new GLP-1 weight loss pill could reach market in 2026
Drugmaker Eli Lilly says after successful results in a phase 3 clinical trial, it expects to submit a GLP-1 weight loss pill for FDA approval by the end of the year. The pill does not produce the same amount of weight loss as injections,
In a clinical trial, the company's weight loss pill resulted in a nearly 12% weight loss at 72 weeks for participants who took the highest dose of the medication. On average, participants lost 7.8% to ...
Eli Lilly will seek regulatory approval for its next-generation weight-loss pill by year-end, based on data that suggests it ...
Trials of a daily obesity pill have shown it can help patients lose around 12% of their body weight over 72 weeks. The ...
Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...
Weight-loss drugs are expected to pull in more than $150 billion in industry-wide revenue by the early 2030s, thanks to the ...
Are weight loss shots like Ozempic and Wegovy safe long-term? It’s complicated. Some early studies suggest thyroid concerns ...
People who ate more typical home-cooked meals lost twice the weight of people eating ultraprocessed foods that met healthy ...
Adjusted Despite Literally Everything," the Disney alum reveals they underwent an “extreme regimen” for a 'Hunger Games' role ...
Plus, studies show that a high-protein diet can help with losing fat and gaining muscle at the same time. Research shows that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback